Search research articles
Contact Us
Filters
Showing results (61-70 of 64) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 64 results.
Proceedings of the National Academy of Sciences of the United States of America
|
August 25, 2018
Moving beyond panaceas in fisheries governance
Oran R Young, D G Webster, Michael E Cox, et al.
The Journal of Clinical Investigation
|
March 26, 2024
Oncogenic ETS fusions promote DNA damage and proinflammatory responses via pericentromeric RNAs in extracellular vesicles
Peter Ruzanov, Valentina Evdokimova, Manideep C Pachva, et al.
Cancer Research
|
April 3, 2009
Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer
Gerhardt Attard, Joost F Swennenhuis, David Olmos, et al.
Oncotarget
|
May 8, 2018
Statin use and survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: the international retrospective observational STABEN study
Jacob A Gordon, Carlo Buonerba, Gregory Pond, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 64) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 64 results.
Proceedings of the National Academy of Sciences of the United States of America
|
August 25, 2018
Moving beyond panaceas in fisheries governance
Oran R Young, D G Webster, Michael E Cox, et al.
The Journal of Clinical Investigation
|
March 26, 2024
Oncogenic ETS fusions promote DNA damage and proinflammatory responses via pericentromeric RNAs in extracellular vesicles
Peter Ruzanov, Valentina Evdokimova, Manideep C Pachva, et al.
Cancer Research
|
April 3, 2009
Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer
Gerhardt Attard, Joost F Swennenhuis, David Olmos, et al.
Oncotarget
|
May 8, 2018
Statin use and survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: the international retrospective observational STABEN study
Jacob A Gordon, Carlo Buonerba, Gregory Pond, et al.
Page
of 7